Allogene Therapeutics (ALLO) Prepaid Assets (2018 - 2026)

Allogene Therapeutics has reported Prepaid Assets for 9 years, with the latest figure at $6.4 million in Q1 2026.

• Quarterly Prepaid Assets fell 44.45% year-over-year to $6.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $6.4 million (down 44.45% YoY) and the FY2025 annual result came in at $7.5 million, down 30.9% from the prior year.
• Prepaid Assets retreated to $6.4 million in Q1 2026 per ALLO's latest filing, from $7.5 million in the prior quarter.
• Over five years, Prepaid Assets peaked at $22.5 million in Q2 2022 and troughed at $6.4 million in Q1 2026.
• A 5-year average of $11.8 million and a median of $10.5 million in 2024 frame the typical range for Prepaid Assets.
• The sharpest annual moves came in 2023 and 2024: Prepaid Assets plunged 55.01% in 2023, then jumped 61.67% in 2024.
• Over 5 years, Prepaid Assets stood at $11.5 million in 2022, then dropped by 9.44% to $10.4 million in 2023, then climbed by 4.72% to $10.9 million in 2024, then plunged by 30.9% to $7.5 million in 2025, then decreased by 15.02% to $6.4 million in 2026.
• According to Business Quant data, Prepaid Assets over the past three periods registered $6.4 million, $7.5 million, and $8.5 million for Q1 2026, Q4 2025, and Q3 2025 respectively.